Trial Profile
Evaluating Effects of Complera and Stribild in pre switch genotypes containing significant resistance in HIV patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 May 2019
Price :
$35
*
At a glance
- Drugs Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat (Primary) ; Emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 31 Dec 2015 New trial record